Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home › Topics › Infectious Diseases › Reference Library ›Influenza references ›   Seasonal Influenza Publications
Printer friendly page (opens in new window)

Seasonal Influenza Publications

Seasonal Influenza Publications

Influenza Annual Reports

2007-2008 Mook P, Pebody R, Zhao H, Ellis J, Zambon M, Fleming DM, Watson JM.  Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2007 to May 2008 Supplement available at: http://www.hpa.org.uk/hpr/archives/Infections/2008/respiratory.htm#ann0708

2006-2007 Mook P, Joseph CA, Ellis J, Zambon M, Fleming DM, Watson JM .  Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2006 to May 2007. Health Protection Report 2008 Supplement. Available at: http://www.hpa.org.uk/hpr/archives/2008/hpr2308.pdf.

2005-2006 Desai S, Zhao H , Cooke MK, Joseph CA, Ellis J, Zambon M, Fleming DM, Watson JM.  Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2005 to May 2006. CDR Weekly 2006 Supplement. Available at: http://www.hpa.org.uk/cdr/archives/2006/flu_2006.pdf.

2004-2005 Zhao H, Cooke MK, Joseph CA, Ellis J, Zambon M, Fleming DM, Nguyen-Van-Tam JS, Watson JM. Influenza and other respiratory viruses surveillance in the United Kingdom: October 2004 to May 2005. CDR Weekly 2005 Supplement. Available at: http://www.hpa.org.uk/cdr/archives/2006/flu_2005.pdf.

2003-2004 Cooke MK, Crofts JP, Joseph CA, Goddard NL, Ellis J, Zambon M, Fleming DM, Nguyen-Van-Tam J, Watson JM. Influenza and other respiratory viruses survellance in the United Kingdom October 2003 to May 2004. Commun Dis Rep CDR Suppl [serial online] 2005 [cited 4 January 2006]; 15 (1): 1-8.

2002-2003 Crofts JP, Joseph CA, Zambon M, Ellis J, Fleming DM, Watson JM. Influenza survellance in the United Kingdom October 2002 to May 2003. Commun Dis Rep CDR Suppl [serial online] 2004 [cited 4 January 2006]; 14 (1): 1-9.

2001-2002 Crofts JP, Goddard NL, Joseph CA, Zambon M, Ellis J, Fleming DM et al. Influenza surveillance in the United Kingdom: October 2001 to May 2002. Commun Dis Rep CDR Suppl 2002; 12 (1): 1-7.

2000-2001 Goddard NL, Joseph CA, Zambon M, Nunn M, Fleming D, Watson JM. Influenza surveillance in the United Kingdom:October 2000 to May 2001. Commun Dis Rep CDR Suppl 2001; 11(Suppl 1): 1-7.

 

Influenza Diagnosis

Ellis JS. Influenza A H1N2 viruses. ESWI Bulletin 16. pg 5.

Ellis JS, Alvarez-Aguero A, Gregory V, et al.  Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season. Emerg Infect Dis 2003; 9(3):304-10.

Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, Heath P, Murdoch I, Zambon M, George R, Miller E. Severe and unrecognised Pertussis in UK infants. Archiv Dis Childhood2003; 88: 802-6.

McKimm-Breschkin JL, Trivedi T, Hamspon AH, Hay A, Klimov A, Tashiro M, Hayden F and Zambon M on behalf of the Neuraminidase Inhibitor Susceptibility Network (NISN). Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. AntiMicrobial agents & Chemotherapy 2003; 47: 2264-72

Stephenson I, Wood JM, Nicholson KG, Zambon MC. Change in Receptor Specificity of Erythrocytes affects Haemagglutination-Inhibition Detection of Antibodies to Avian Influenza Haemagglutinin J Med Virol 2003; 70: 391-8

Paget WJ, Zambon M, Uphoff H, Bartelds A on behalf of EISS. Declining influenza activity and no indication that media coverage associated with SARS has led to an increase in ILI/ARI consultations in family practice. Eurosurveillance Weekly 2003: 15

Stephenson I, Nicholson KG, Colegate A, Podda A, Wood J, Ypma E, Zambon MC .Boosting immunity to influenza H5N3 with MF59 adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population. Vaccine Apr 2003.; 2;21(15):1687-93.

Ellis JS, Alvarez-Aguero A, Gregory V., YP Lin, A Hay, MC Zambon. Influenza AH1N2 viruses and their impact during the 2001-02 influenza season in the United Kingdom. Emerg Infect 2003; 9: 304-10.

Loeffen WLA, Heinen PP, Bianchi ATJ, Hunneman WA, Verheijden JHM. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infections with an influenza H1N1 virus. Vet Immunol Immunopathol. 2003; 92(1-2):23-35.

Loeffen WL, Nodelijk G, Heinen PP, van Leengoed LA, Hunneman WA, Verheijden JH. Estimating the incidence of influenza-virus infections in Dutch weaned piglets using blood samples from a cross-sectional study. Vet Microbiol2003; 91(4) : 295-308.

Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003; 21: 902-14.

Harnden A, Sheppard S, Brueggmann A, White J, Crook D, Zambon M, Mant D . Near Patient Testing for influenza in primary care: a prospective case series. BMJ 2003; 326: 480.

N.T. Wetherall, T. Trivedi J. Zeller, C. Hodges-Savola, F.G. Hayden, M. Zambon, (2003). Evaluation of Neuraminidase Enzyme Assays using different substrates to measure the susceptibility of Influenza Clinical Isolates to Neuraminidase Inhibitors. J Clin Micro 2003; 41: 742-50.

Wood, JM, Melzack D, Newman RW, Major DL, Zambon MC, Nicholson KG, et al. A single radial haemolysis assay for antibody to H5 haemagglutinin. In: Osterhaus A, Cox N, Hampson A, editors. Options for the Control of Influenza IV. International Congress Series 2001; 1219: 761-66. Elsevier.

Zambon MC, Ellis JS. Molecular methods for diagnosis of influenza. In: Osterhaus A, Cox N, Hampson A, editors. Options for the Control of Influenza IV. International Congress Series 2001; 1219: 267-73. Elsevier.

Ellis JS, Zambon MC . A heteroduplex mobility assay for the detection of influenza A strains from different species. J Clin Micro 2001; 39: 4097-102.

Zambon M, Hayes J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.
Arch Intern Med 2001; 161: 2116-22.

Boon AC, French AM, Fleming DM, Zambon MC. Detection of influenza A subtypes in community-based surveillance. J Med Virol 2001; 65: 163-70

 

Vaccination and Treatment

Fleming DM and Elliot AJ. Estimating the risk population in relation to influenza vaccination policy. Vaccine 2006;24:4378-85.

Joseph CA, Goddard NL. Influenza vaccine uptake in the elderly: Results from a rapid assessment of the effectiveness of new government policy in England for the winters 2000/01 and 2001/02.Vaccine 2003; 21 (11-12): 1137-48.

Wood JM, Nicholson KG, Zambon MC, Hinton R, Major DL, Newman RW, et al. Developing vaccines against potential pandemic influenza vaccines. In: Osterhaus A, Cox N, Hampson A, editors. Options for the Control of Influenza IV. International Congress Series Elsevier, 2001; p751-61.

Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, et al. Confronting a potential H5N1 pandemic: a randomised controlled trial of conventional and MF59 adjuvanted influenza A/Duck/Singapore/97 (H5N3) surface antigen vaccine. Lancet 2001; 357: 1937-43.

Lawson TM, Man S, Williams S, Boon ACM, Zambon MC, Borysiewicz. Influenza A antigen exposure selects dominant V (beta) 17(+) human CD8 (+) cytotoxic T cell responses. Int Immunol; 2001; 13: 1373-81.

Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JIO, et al. Antibody responses to vaccinations given before two years post transplant are similar between autologous peripheral stem cell and bone marrow transplant recipients. Bone Marrow Transplantation 2001; 28: 775-81.

Zambon M, Hayden FG. Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res 2001; 49: 147-56.

Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 2001; 357: 1937-43.

Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zambon M. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001; 84: 496-500.

Surveillance

Mook P, Joseph C, Gates P, Phin N, . Pilot scheme for monitoring sickness absence in schools during the 2006/07 winter in England: can these data be used as a proxy for influenza activity?. Euro Surveill 2007;12(12)[Epub ahead of print]. Available online: http://www.eurosurveillance.org/em/v12n12/1212-226.asp

Zhao H, Joseph C, Phin N. Outbreaks of influenza and influenza-like illness in schools in England and Wales, 2005/06. Euro Surveill 2007;12(5) [Epub ahead of print]. Available online: http://www.eurosurveillance.org/em/v12n05/1205-222.asp

Deckers JG, Paget WJ, Schellevis FG, Fleming DM. European primary care surveillance networks: their structure and operation. Fam Pract 2006;23:151-8.

Elliot AJ and Fleming DM. Surveillance of influenza-like illness in England and Wales during 1966-2006. Euro Surveill  2006;11:249-50.

Meerhoff TJ, Fleming D, Smith A, Mosnier A, Gageldonk-Lafeber AB, Paget WJ. Surveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System. BMC Infect Dis 2006;6:128.

Harcourt SE, Edwards DE, Fleming DM, Smith RL, Smith GE. How representative is the population covered by the RCGP spotter practice scheme? Using Geographical Information Systems to assess. J Public Health (Oxf) 2004;26:88-94.

Goddard NL, Kyncl J and Watson JM. Appropriateness of thresholds currently used to describe influenza activity in England. Commun Dis Public Health 2003;6 (3): 238-245.

Goddard NL, Joseph CA, Watson JM, Ellis J, Zambon MC. Three years of low influenza activity - no reason for complacency. Comm Dis Public Health 2003; 6: 128-32.

Watson JM, Zambon MC. NHS Direct and influenza epidemics (rapid response). BMJ 2003. Available at

Ellis JS, Alvarez-Aguero A, Gregory V, Lin YP, Hay A, Zambon MC. Influenza AH1N2 viruses and their impact during the 2001-02 influenza season in the United Kingdom. Emerging Infections 2003; 9: 304 -10.

Gregory V, Bennett M, Orkhan MH, Hajjar AL, Varsano N, Mendelson E. Emergence of influenza A H1N2 reassortant viruses in the human population during 2001. Virology 2002; 300: 1-7.

Paget WJ, Meerhoff TJ, Goddard NL. Mild to moderate influenza activity in Europe and the detection of novel A (H1N2) and B viruses during the winter of 2001-2002. Euro Surveillance 2002 Nov;7(11):147-57

Reagan CM, Johnstone F, Joseph CA, Urwin M. Local Surveillance of influenza in the United Kingdom: from sentinal general practices to sentinel cities? Commun Di. Public Health 2002; 5 (1): 17-22.

Cooper DL, Smith GE, Hollyoak VA, Joseph CA, Johnson L, Chaloner R. Use of NHS Direct calls for surveillance of influenza - a second years's experience. Commun Dis Public Health 2002; 5, (2): 127-31.

Paget WJ, Aguilera JF (on behalf of EISS). Influenza Pandemic Planning in Europe. Eurosurveillance 2001; 6: 136-40.

Manugerra JC, Mosnier A, Paget WJ (on behalf of EISS). Monitoring of influenza in the EISS European network member countries from October 2000 to April 2001. Eurosurveillance 2001; 6 127-35.

Boon ACM, French A, Fleming DM, Zambon MC. Detection of Influenza A in community based surveillance.
J Med Virol 2001; 65 163-70.

Harcourt S, Smith G, Hollyoak V, Joseph CA et al. Can calls to NHS Direct be used for syndromic surveillance? Commun Dis Public Health 2001; 4, (3): 178-88.

 

Epidemiology

Fleming DM, Elliot AJ, Cross KW. Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods. Epidemiol Infect 2007;1-10.

Rizzo, C, Bella A, Viboud C, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis 2007; 13(5): 694-699 [Available online].

Viboud C, Tam T, Fleming D, et al. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg infect Dis 2006; 12(4):661-668 [Available online].

Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005;59:586-90.

Watson JM, Goddard N, Joseph C, Zambon MC. Influenza: the impact of the 1999/2000 epidemic on morbidity and mortality in the UK. In: Osterhaus ADME, editor. Options for the Control of Influenza. Elsevier, 2001. p21-3.

Zambon MC. Shifty drifter up to no good. Lancet Infect Dis 2002; 2: 269-70.

Zambon MC. Influenza and respiratory syncytial virus. Medicine: 29: 118-22.

Zambon MC, Stockton JD, Clewley JP, Fleming DM. Influenza or RSV? Community cases of influenza like illness. Lancet 2001; 358 1410-6.

 

Other seasonal respiratory illnesses

Fleming DM, Pannell RS, Elliot AJ, Cross KW. Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child 2005;90:741-6.

Stockton J, Stephenson I, Fleming DM, Zambon M. Human. Metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis 2002; 8 (9): 897-901.

Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358: 1410-6.

 

General

Fleming DM and Elliot AJ. The impact of influenza on the health and health care utilisation of elderly people. Vaccine 2005;23 Suppl 1:S1-S9.

Ison MG, Mills J, Openshaw P, Zambon M C, Osterhaus ADME, Hayden FG. Current Research on Respiratory Viral Infections: Fourth International Symposium on Respiratory Viruses.
Antiviral Res 2002; 55 227-78.

Zambon MC.The pathogenesis of influenza in humans. Rev Med Virol 2001; 11: 227-241.

Fleming DM, Zambon M. Update in influenza and other viral pneumonias. Curr Opin Infect Dis 2001; 14: 199-204.


Last reviewed: 26 November 2008